To treat amblyopia, or lazy eye, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.
In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.
Doxy-PEP can be taken a few hours after sex and is effective at preventing sexually transmitted infections. New research finds it's less effective for women but that may not be the final word.
An experimental technology that might someday allow infertile couples, as well as gay and trans couples, to have genetically related children stirs hope. So far, the technique has worked in mice.
The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.
A small study found that electrically stimulating an area deep in the brain allowed people with severe traumatic brain injuries to complete a cognitive test more quickly.
A Montana treatment center is one of two places in the U.S. offering long-term residential behavioral treatment for kids as young as 4. Now, administrators say it might have to close.
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate.
The flu almost killed a 34-year-old man who was addicted to vaping. But an innovative doctor – and some DD-sized breast implants – made him eligible for a transplant.
Advisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.
An artificial intelligence upgrade could be coming soon to a computer program called UpToDate that is used by more than 2 million health care professionals to make decisions about patients' care.
Hungarian-born biochemist Katalin Karikó and American immunologist Drew Weissman found that a chemical change to genetic code called mRNA eliminated a problematic side effect when used in vaccines.